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Recent studies have revealed that T  cell proliferation, although initiated by 
antigen or lectin, is actually mediated by a  lymphocytotrophic hormone desig- 
nated as interleukin 2 (IL-2) 1 (1-4). As detailed previously (5, 6), the IL-2-T cell 
interaction is effected by means of binding sites on membrane molecules that 
satisfy the criteria indicative of authentic hormone receptors, i.e., high affinity, 
saturability, ligand specificity, and target cell specificity. The biologic relevance 
of IL-2-specific receptors is reflected by the coincidence of the IL-2 binding and 
proliferative response curves, and further, by the finding that the rate of the T 
cell proliferative response is directly dependent on the concentration of IL-2 
available to the cells (4, 6).  Moreover, monoclonal antibodies reactive with IL-2 
or the  IL-2  receptor inhibit  T  cell proliferation by preventing IL-2-receptor 
binding (7,  8).  The immunologic importance of the IL-2 receptor system and 
the unique nature of this hormone receptor mechanism stem from the finding 
that IL-2 receptors must be induced by appropriate immune stimuli (5, 9,  I0). 
Thus,  the immune specificity of T  cell cional expansion is guaranteed by the 
restriction of IL-2 receptor expression only to antigen-activated T  cell clones. 
The long-term culture of T  cell clones depends upon an initial selection of IL- 
2 receptor-bearing cells, together with the provision of adequate IL-2 concentra- 
tions (3, 9-1 1). However, soon after the demonstration of IL-2-dependent T cell 
growth,  it  was  noted  that  IL-2  responsiveness  decayed with  time  (12,  13). 
Although this phenomenon could be prevented or reversed by the reintroduction 
of the original  stimulating antigen,  or by using lectin-containing conditioned 
medium, the mechanism responsible for the loss of IL-2 responsiveness was not 
readily apparent.  Moreover, the ephemeral nature of the IL-2 responsiveness 
suggested that this phenomenon could be physiologically relevant to the regula- 
tion of T  cell growth. 
As the biologic importance of IL-2  receptors became better appreciated, it 
appeared that fluctuating IL-2 responsiveness might be attributable to transient 
cellular  IL-2  receptor expression.  Accordingly, with  the  development of the 
capacity to  examine IL-2  receptors both  quantitatively and qualitatively, this 
issue became amenable to analysis. Using IL-2 rendered homogeneous by mono- 
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clonal antibody affinity purification (7),  biosynthetically radiolabeled  IL-2 (5), 
and anti-Tac (a recently described IL-2 receptor monoclonal antibody) (8,  14, 
15),  the growth characteristics of activated T  cells were determined and corre- 
lated with  IL-2  receptor  expression.  IL-2  receptors  appear  asynchronously in 
iectin-activated  human  peripheral  blood  T  cell  populations.  Moreover,  upon 
removal of the activating lectin, IL-2 receptor levels do not persist. Rather, there 
occurs a time-related and IL-2-independent decay of IL-2 receptors that is rapidly 
reversible by restimulation with lectin. As receptor appearance and disappearance 
is mirrored by the proliferative rate of the cells, these observations suggest that 
IL-2 receptor levels are of primary importance in determining the extent of T 
cell clonal expansion, and consequently, the tempo and magnitude of the result- 
ant T  cell immune response. 
Materials and Methods 
Cell Cultures.  To  avoid  possible  variables  resulting  from  the  selection  of T  cell 
populations (introduced either as a result of the method of selection or as a result of the 
loss  of cells  during  the  selection  process),  whole  peripheral  blood  mononuclear cell 
populations were chosen for study. Human peripheral blood mononuclear (PBM) cells 
isolated by Ficoil-Hypaque discontinuous gradient centrifugation and Jurkat subcione 6.8 
cells (6) were cultured in RPMI  1640  medium (Gibco Laboratories, Grand Island, NY) 
supplemented with 10% heat-inactivated (56°C,  30 min) fetal calf serum (FCS) (Sterile 
Systems,  Inc., Logan, UT),  50 U/ml penicillin G, 50 #g/ml gentamicin, 300 ttg/ml L- 
glutamine, 5 ttg/ml insulin, 5 #g/ml transferrin, and 5 ng/ml selanous acid (ITS, Collab- 
orative Research, Inc., Lexington, MA) in a humidified atmosphere of 5% CO2 in air. 
PBM cells were stimulated with phytohemagiutinin (PHA) (1 ~tg/ml; Wellcome Reagents, 
Ltd., Beckenham, England) for 72 h, after which the cells were washed free of iectin and 
replaced into culture with receptor-saturating concentrations of IL-2 (500 pM) as indi- 
cated. 
Murine IL-2-dependent cytolytic T  lymphocyte lines (CTLL-2, subclone 15 G) were 
maintained as previously described (16) at population levels between 1 x  104 and 5 x  105 
cells/ml in Iscove's modified Dulbecco's minimum essential medium (17) supplemented 
with  10%  FCS,  50  U/ml penicillin G, 50 ttg/ml gentamicin, and 500 pM human IL-2 
derived from Jurkat T  leukemia cells and partially purified by gel filtration (18). 
Production  and  Preparation  of Affinity-pur~ed  IL-2.  Jurkat  subclone  6.8  cells  were 
routinely harvested from the exponential phase of cell growth (0.8-1.0  x  106 cells/ml), 
centrifuged (250 g,  10 rain),  placed into serum-free DMEM (Gibco  Laboratories), and 
cultured at 4.0  x  106 celis/ml for  14-18  h  in the presence of PHA (1.5  #g/ml) and 
phorbol myristic acetate (50 ng/ml; Consolidated Midlands Corp., Brewster, NY). The 
cell-free supernatant was harvested by centrifugation (1,000 g,  15  rain),  filtered (0.45 
#m), and stored at 4°C.  Biosynthetically radiolabeled [3H]leu,lys-IL-2  was prepared as 
described previously (5, 6). 
Radiolabeled and unlabeled IL-2 were isolated from contaminating proteins in the cell- 
free culture supernatants by a  one-step purification protocol using an immunoaffinity 
column constructed with an  IgG2a monoclonal antibody to  IL-2  (designated DMS-3) 
produced using the methods of de St. Groth and Scheidegger (19) as described in detail 
elsewhere (7). The immunoaffinity column was washed with 10 mi 0.2 N acetic acid (pH 
3.0) and neutralized with 10 mM Tris-HCl, pH 7.5, before passage ofJurkat supernatants. 
After application of the supernatant, the column was washed with 20 column volumes 
each of 1 M NaC1, 10 mM Tris-HCl,.pH 7.5; 0.5% Nonidet P-40,  10 mM Tris-HCi, pH 
7.5;  10 mM Tris-HCl, pH 7.5; and H,~O. Bound IL-2 was eluted with 5 column volumes 
of 0.2 N acetic acid in two fractions (2 and 3 ml). Typically, >90% of the bound material 
appeared in the first fraction. The eluted protein was assayed for biologic activity and 
analyzed by sodium dodecyl sulfate-polyacrylamide  gel electrophoresis (SDS-PAGE) in the CANTRELL AND  SMITH  1897 
presence of reducing agents according to the method of Laemmli (20) (12% acrylamide). 
Radioactive proteins were visualized by fluorography using EN3HANCE (New England 
Nuclear, Boston, MA).  Analysis of the unlabeled IL-2 eluted from the immunoaffinity 
adsorbant is described in detail elsewhere (7).  The eluted material was comprised of a 
single protein (Mr, 15,500), as far as could be determined by SDS-PAGE, reverse-phase 
liquid chromatography, and amino-terminal amino acid sequence analysis (7). 
The specific activity of the radiolabeled IL-2 was determined by relating radioactivity 
to  biologic activity.  Biologic activity and  protein  mass  were  determined  on  similarly 
purified unlabeled IL-2. Protein assays (dye binding and amino acid analysis) consistently 
yielded the result:  1 U biologic activity -  8.2 ng protein. Using the value of 15,500 Mr 
for IL-2, the specific activity of the [3H]leu,lys-IL-2 was calculated as 53,437 dpm/U or 
94,400 dpm/pmol. 
IL-2 Biologic Activity.  I L-2 activity was determined as previously described (21) by the 
I L-2 concentration-dependent stimulation of proliferation of a cloned CTLL (16). CTLL 
proliferation, as monitored by ['~H]thymidine (TdR) incorporation (2.0 #Ci/ml, sp act 1.9 
Ci/mM;  Schwartz/Mann  Div., Becton, Dickinson & Co.,  Orangeburg,  NY),  was  deter- 
mined during the last  4  h  of a  24-h  culture period in  the presence of serial twofold 
dilutions of a standard IL-2 preparation and the experimental sample. The dilutions that 
yielded 50% of the maximal CTLL ['~H]TdR incorporation were determined by probit 
analysis;  dilution values of the samples were divided by that of the standard to give the 
concentration of IL-2 in units per milliliter. The standard IL-2 preparation, which had 
been arbitrarily assigned a value of 1 U/ml, routinely yielded 50% of the maximal [3H]- 
TdR incorporation at a dilution of 1:10.  Using a value of 8.2 ng/U, a concentration of 1 
U/ml was determined to be 5.3 x  10  -~° M. 
Radiolabeled  IL-2-binding  Assay.  Radiolabeled  IL-2  binding  to  whole  cells  was  per- 
formed as described in detail previously (5, 6). All cells were prepared for the assay by 
centrifugation, followed by incubation at 37°C in IL-2-free RPMI 1640 medium (50 ml/ 
1 x  107  cells)  for  two  1-h  intervals  to  promote  dissociation  and/or  degradation  of 
endogenously bound IL-2. These conditions were chosen based upon the dissociation rate 
constant previously determined for intact cells and isolated plasma membranes (t~/2 for 
dissociation is 25 rain) (5, 6). Serial dilutions of [SH]leu,lys-IL-2  were incubated with cells 
(1  x  106 cells/0.2 ml) in RPMI  1640 medium,  1 mg/ml bovine serum albumin (BSA) at 
37°C. After a 20-min incubation, cold (4°C) RPMI  1640-BSA (1 ml) was added and the 
cells centrifuged (9,000 g,  15 sec). The supernatant containing the unbound fraction was 
removed and counted via liquid scintillation. The cell pellet was resuspended in  100 t~l 
cold RPMI  1640-BSA and  centrifuged (9,000 g,  90  sec)  through a  200-#1 layer of a 
mixture of 85% silicone oil (Dexter Hysol 550 fluid; Dexter Corp., Orlean, NY) and 16% 
paraffin oil  (No.  0-119;  Fisher  Scientific Co.,  Fair  Lawn,  NJ).  The tips  of the  tubes 
containing the cell pellet were cut off and counted by liquid scintillation to determine the 
level of bound radioactivity. The calculated values of the number of binding sites per cell 
were obtained by Scatchard analysis of equilibrium binding data, after subtraction of the 
nonsaturable binding determined in the presence of a 150-fold molar excess of unlabeled 
IL-2. The lower limit of detection of receptor sites per cells was 200. 
Flow Microfluorometry.  Expression of surface anti-Tac binding was examined by flow 
cytofluorometry. Cells at 107/ml were incubated (1 h, 4°C) with saturating concentrations 
(1:5,000 dilution of ascites) of the anti-Tac monoclonal antibody (kindly provided by Dr. 
Takashi Uchiyama and Dr. Thomas Waldman) (8, 14,  15), washed three times, and then 
incubated  (1  h,  4°C)  with  a  saturating  concentration  (1:20  dilution)  of fluorescein- 
conjugated rabbit anti-mouse Ig (Dakopatts; Accurate Chemical & Scientific Corp., West- 
bury, NY). Mature T  cells were analyzed using identical methods by indirect immunoflu- 
orescence with the OKT3, OKT4, and OKT8 monoclonal antibodies (Ortho Pharma- 
ceutical Corp., Raritan,  NJ) together with fluorescein-conjugated rabbit anti-mouse Ig. 
For analysis  of the cellular DNA content of cells,  106 cells were labeled with the DNA- 
binding dye, propidium iodide (PI) (50 #g/ml; Calbiochem-Behring Corp., La Jolla, CA) 
in the presence of 100 Kunitz U/ml RNAase (Sigma Chemical Co., St. Louis, MO), I. 12% 1898  INTERLEUKIN  2  RECEPTORS  AND  T  CELL  GROWTH 
sodium citrate, and 0.05% Nonidet P-40. Samples were passed on an Ortho cytofluoro- 
graph (System 50H; Ortho Diagnostic Systems, Inc., Westwood, MA) using an argon ion 
laser (Spectra-Physics, Inc., Mountain View, CA) at 488 nm excitation wavelength. Green 
fluorescence was observed  using a 515-530-nm band pass filter.  Red fluorescence was 
observed using a 630-nm-long pass filter. A minimum of 10,000 cells, gated to exclude 
nonviable cells, was accumulated for each histogram. 
All data were analyzed using the Ortho 2150 Data Handler System (Ortho Diagnostic 
Systems, Inc.). For analysis of  anti-Tac fluorescence, the emission was measured in relative 
units (channel number). A comparison of fluorescence intensity was made using the mean 
channel number for different histograms. The percentage ofanti-Tac  + cells was calculated 
against a background of nonspecific labeling obtained using normal Ig (1-3%). For DNA 
analysis, the data were plotted as linear histograms of DNA content. The relative number 
of cells in the Go/G, phase of the cell cycle was estimated using the quick estimate method 
of cell cycle  analysis provided with the 2150 Data Handler software. 
Subsets with either high or low anti-Tac reactivity were isolated using the cell sorting 
facility available with the cytofluorograph. After the cell sorting procedure, unbound 
anti-Tac was removed from the cell suspensions by washing, and unseparated  and sepa- 
rated cells were placed into culture in the presence of a receptor-saturating  concentration 
of IL-2 (500 pM). [SH]TdR incorporation  was determined by a  2-h incubation  at the 
initiation of the culture and after 22 h of culture in the presence of IL-2. Although anti- 
Tac blocks IL-2 receptor binding,  this effect is antibody concentration dependent and 
complete  suppression  of the  proliferative  response  to  IL-2  requires  the  continuous 
presence of high concentrations (50 #g/ml, 3.3 x  10-TM) ofanti-Tac (8). 
['~H]TdR Incorporation.  The proportion of S phase cells in various cell populations was 
estimated by monitoring [3H]TdR (2.0 #Ci/ml; Schwartz/Mann  Div., Becton, Dickinson 
& Co.) incorporation  during 2-h culture intervals at the times indicated. Cultures were 
terminated by precipitation onto glass fiber filters and were counted by liquid scintillation. 
Data are expressed as cpm [3H]TdR incorporated by 104 cells placed in culture. 
Results 
Purification  of Biosynthetically  Radiolabeled  IL-2.  After elution and neutraliza- 
tion of the [3H]-labeled protein bound to the DMS-3  immunoaffinity column, 
the  fractions  were  tested  for  biologic  activity.  Using  cloned  murine,  IL-2- 
dependent cytolytic cells  and  [3H]TdR  incorporation  as  an  indicator of cell 
proliferation, serial  twofold dilutions of the  eluted  fractions were  tested.  As 
shown  in  Fig.  1,  the  first  fraction  contained  IL-2  activity that yielded  50% 
maximal CTLL [3H]TdR incorporation at a sample dilution of 1:3,000, whereas 
the second fraction titrated in a similar fashion yielded comparable activity at a 
dilution of i :435. Since the laboratory standard in this assay titered 1:22, fraction 
1 contained  136  U/ml and fraction 2  contained 20  U/ml. The fractions were 
combined, adjusted to 20 U/ml in RPMI 1640,  1 mg/ml BSA, and examined by 
SDS-PAGE.  As shown in Fig.  2, a  fluorograph of the preparation produced a 
single band of radiolabeled protein at 15,500 Mr. 
Time  Course  of Receptor  Appearance  and  Cellular  Proliferative  Response  to  IL- 
2.  Previous studies have revealed that two time-related events precede the onset 
of T  cell proliferation after lectin activation: IL-2 production and the acquisition 
of  IL-2  receptors  (9,  10,  21,  22).  In  these  earlier  studies,  maximum  IL-2 
concentrations  occurred  within  24-48  h  as  detected  by  the  IL-2  bioassay; 
however, the kinetics of IL-2 receptor appearance could only be surmised by 
testing for IL-2 responsiveness or absorptive capacity. Therefore, in the present 
study, the time course of receptor induction was examined directly, both quan- CANTRELL  AND  SMITH  1899 
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FIGURE  1.  Biologic activity of immunoaffinity-purified  IL-2. Murine CTLL, subclone 15H 
cells were cultured (4 ×  104 cells/ml) for 20 h with the indicated dilutions of the experimental 
samples (fraction I, V; fraction 2, II; laboratory standard, Q) followed by a  4-h exposure to 
[3H]TdR.  In parallel, each  sample was also tested  without the  [3H]TdR exposure and the 
difference in cpm from  the  two  sets  of cultures was  used  to  determine cellular [SH]TdR 
incorporation. Maximum cpm, 23,645; minimum cpm, 22. 
FIGURE 2.  Fluorograph of SDS-PAGE analysis of immunoaffinity-purified  IL-2. [SH]leu,lys- 
IL-2 (20,000 dpm) is shown (12% acrylamide). Molecular weight markers included lysozyme 
(14.4 K), soybean trypsin inhibitor (21.5 K), ovalbumin (45 K), and bovine serum albumin (66 
K). Radiographic exposure time, 6 d. 
titatively  and  qualitatively,  by  means  of radiolabeled  IL-2  binding and  flow 
microfluorometry using anti-Tac.  In addition,  simultaneous measurements of 
[3H]TdR  incorporation and cytofluorometric analysis using the  DNA-binding 
dye,  PI,  provided  estimates  for  the  onset  of  DNA  synthesis  and  cell  cycle 
progression. 1900  INTERLEUKIN  2  RECEPTORS  AND  T  CELL  GROWTH 
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FIGURE 3.  The kinetics of IL-2 receptor induction (left)  and cell cycle progression (right)  of 
PHA-stimulated  human  PBM.  1L-2  receptor  induction  was  examined  by  [SH]leu,lys-IL-2 
binding and by indirect immunofluorescence using the anti-Tac monoclonal antibody and 
fluorescein isothiocyanate-conj  ugated rabbit anti-mouse Ig. The I L-2 receptor profiles of cells 
cultured without lectin were indistinguishable from those of noncultured PBM. The percentage 
anti-Tac cells were "estimated against a background of nonspecific labeling with normal mouse 
Ig of 1.7%.  The mean channel numbers for fluorescence emissions were 37,  105,  190, and 
450 for t =  0, 24, 48, and 72 h, respectively. Cell cycle distributions of human PBM at different 
times after exposure to PHA were monitored using the PI-fluorescence technique. [SH]TdR 
incorporation data were determined as described in Material and Methods. 
A  typical  experiment, representative  of five assays  of the  kinetics of IL-2 
receptor induction and cellular proliferation after exposure of human PBM cells 
to PHA, is shown in Fig. 3. As reported previously, and displayed in Fig. 3A, 
binding of radiolabeled IL-2 and anti-Tac to freshly isolated human PBM cells 
was undetectable (5, 8,  14,  15). Consistent with the absence of these phenotypic 
markers of activation, the cells incorporated low levels of [SH]TdR and yielded 
a single peak of DNA staining using the PI fluorescence technique, indicative of 
a quiescent cell population arrested in the Go/GI phase of the cell cycle (Fig. 3B). 
Upon  the  addition  of lectin,  detectable  levels  of  IL-2-binding sites  became 
evident by  6  h;  by  24  h,  37%  of the cells expressed anti-Tac  reactivity and 
[3H]leu,lys-IL-2-binding sites were  readily  measurable (Fig.  3C).  Despite  the 
acquisition of IL-2 receptors, [3H]TdR incorporation remained at the prestimu- 
lation level and 95% of the cells remained in the Go/G1 phase of the cell cycle 
(Fig. 3 D). 
By the 2nd d  of culture (Fig.  3E),  the proportion of cells reactive with anti- 
Tac  had  increased  to  47%,  accompanied by a  parallel  increase  in  the mean 
number of IL-2 receptors detectable by the radiolabeled IL-2-binding assay. At CANTRELL  AND  SMITH  1901 
this time, 93% of the cells persisted in the Go/G~  phase of the cell cycle, which 
was reflected by only a  modest increment in [3H]TdR incorporation compared 
with  the  prestimulation  level  (Fig.  3F).  The  lack  of significant  proliferation 
during  this  time  interval,  even  though  detectable  IL-2  receptors  increased 
progressively,  suggests that within the total population, cellular  IL-2  receptor 
acquisition reflects a  gradual and asynchronous accumulative process, and pre- 
cedes the commitment to cell cycle progression. 
Maximal levels of IL-2 receptors were evident after 3 d  of culture (Fig. 3 G). 
By this time, 72% of the cells were reactive with anti-Tac. Since anti-Tac reacts 
only  with  activated  T  cells  (14,  15),  and  since  80%  of the  cells  expressed 
phenotypic markers of mature T  cells at this juncture, these data indicate that 
the majority (90%) of the T  cells within the population expressed detectable IL- 
2  receptors  by  72  h  after  stimulation  with  lectin.  Moreover,  the  additional 
increment in the mean number of IL-2-binding sites per cell, together with the 
marked heterogeneity of receptor expression as shown by the anti-Tac micro- 
fluorometry profile, further support the impression that not only do the majority 
of cells acquire IL-2 receptors but that a progressive increase in the IL-2 receptor 
density per cell also takes place. 
Simultaneous analysis of [~H]TdR incorporation and cellular DNA content of 
the cell population after  72  h  of culture for the first time revealed a  marked 
increase in cycling cells. The rate of [3H]TdR incorporation increased >30-fold 
compared with the freshly isolated cells and 51% of the cells had shifted out of 
Go/Gl (Fig. 3/4). 
IL-2  Dependency  of Cell  Cycle Progression of IL-2  Receptor  + Cells.  Once  the 
majority of cells have acquired IL-2 receptors and have undergone the transition 
from a resting, noncycling state to an actively proliferating population in response 
to IL-2 produced in situ, continued cell cycle progression is dependent upon the 
concentration of IL-2 available. An experiment demonstrating the IL-2 concen- 
tration dependence of [3H]TdR incorporation by IL-2 receptor  + cells is shown 
in Fig. 4. In this experiment, cells harvested after 4 d of culture, expressing high 
levels as well as a broad range of IL-2 receptors as detected by anti-Tac staining 
(Fig. 4, inset), were washed and cultured in medium deprived of IL-2 for 24 h. 
Thereafter,  the  cells were  exposed to affinity-purified IL-2  in concentrations 
ranging from  140 to 0.1  pM. After 24 h, [3H]TdR incorporation, plotted as a 
function of the logarithm of IL-2 concentration, yielded a typical sigmoid dose- 
response curve. It was also notable that IL-2 receptor  + cells isolated from four 
individuals yielded superimposable IL-2 dose-response curves. 
Removal of IL-2 from an actively cycling cell population resulted in a decrease 
in  the  proportion  of S  phase  cells  within  24  h  as  determined  by  [3H]TdR 
incorporation. If I L-2 deprivation was continued, the cells gradually accumulated 
in the Go/G~ phase of the cell cycle: after 72-96 h, the majority of the population 
were  blocked  in  Go/GI  and  resumed  the  morphological appearance  of small 
quiescent lymphocytes. In contrast, cells maintained in saturating concentrations 
of IL-2 continued to cycle during this time period. Thus, it is evident that once 
lectin-activated  T  cells acquire  IL-2  receptors,  the  maintenance of continued 
proliferation is dependent upon an adequate IL-2 concentration. 
Decay  of IL-2  Receptors and  Cellular  Proliferation.  With  the  availability  of 1902  INTERLEUKIN  2  RECEPTORS  AND  T  CELL  GROWTH 
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FIGURE 4.  The IL-2 concentration dependence of [3H]TdR incorporation by IL-2 receptor  + 
cells. Cells harvested after 4 d of culture with PHA were washed and cultured (5 ×  104 cells/ 
ml) with the indicated concentrations of immunoaffinity-purified IL-2 for 20 h followed by a 
4-h incubation with  [SH]TdR.  Data  shown represent the mean _  SEM  from  cells of four 
individuals. Maximum cpm of [3H]TdR incorporated ranged from 5,189 to 15,306; minimum 
cpm (in the absence of IL-2) ranged from 251  to 4,568. Inset: anti-Tac indirect immunofluo- 
rescence of the cells from one of the individuals. 
affinity-purified homogenous IL-2, it was possible, for the first time, to investigate 
the growth of lectin-activated cells once they had acquired maximal levels of IL- 
2 receptors.  In initial experiments, after the cells had been removed from the 
activating signal  provided  by  PHA  and  placed  into  long-term culture  in  the 
presence of saturating concentrations of IL-2 (500 pM, a  fivefold excess of the 
concentration required  to fully saturate  IL-2 receptors [5,  6  and Fig.  4]),  the 
rate  of proliferation  of the  cell  population  slowly  declined.  To  explore  the 
possibility that the progressive loss of IL-2 responsiveness related to a decay in 
cellular IL-2 receptor levels, PHA-stimulated cells were harvested after  3 d  of 
culture, washed, and placed at low cell density (1 ×  105 cells/ml) in fresh medium 
containing a  saturating  concentration of affinity-purified IL-2  (500  pM).  The 
cells were subcultured when the cell concentration approached 1 ×  106 cells/ml, 
at which point IL-2 was replenished to ensure that the IL-2 concentration did 
not become growth limiting. At various time intervals after the initiation of the 
cultures, cell aliquots were removed and IL-2 receptor levels were determined 
by  anti-Tac  staining  and  the  IL-2-binding  assay.  Simultaneously,  the  rate  of 
proliferation was analyzed by PI fluorescence and [3H]TdR incorporation. 
Typically, the population continued in exponential  growth  for several  days 
(from the initiation of culture,  7.2  _+ 0.5  d, mean +  SEM of 10 experiments) 
with a steady doubling time of 18-22 h. During this period, [3H]TdR incorpo- 
ration rates remained relatively constant gnd PI analysis revealed the profile of 
cell  populations  in  asynchronous  exponential  growth.  Consistent  with  these 
growth characteristics, IL-2 receptor levels remained high as determined by both 
anti-Tac reactivity and ['~H]leu,lys-IL-2 binding. In a representative experiment 
detailed  in  Fig.  5A,  where  both  receptor  and  proliferative  parameters  were 
analyzed, the population maintained relatively constant levels of IL-2 receptors 
from day 3 to day 7 (7,000-9,000 sites/cell, 80-95% anti-Tac + cells). Thereafter, 
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FIGURE 5.  IL-2 receptor expression and cell cycle progression of IL-2 receptor  + cells har- 
vested after 3 d of culture with PHA, washed, and exposed to saturating concentrations (500 
pM) of affinity-purified IL-2. (A) IL-2 receptor expression as determined by [SH]leu,lys-IL-2 
binding (O); anti-Tac mean fluorescence intensity (O); and the percentage of anti-Tac  + cells 
(A). (B) Cell cycle progression as monitored by [SH]TdR incorporation (O), and cytofluoro- 
graphic analysis of DNA content using propidium iodide (O). 
mined by quantitative radiolabeled IL-2 binding, was paralleled by a progressive 
diminution of the mean fluorescence intensity of anti-Tac labeling and also by a 
decline in the percentage ofanti-Tac  + cells. Typically, the decline in IL-2 receptor 
levels preceded a decline in the rate of cell proliferation. A fall in receptor levels 
was followed by a  decreased rate of entry into the S phase of the cell cycle as 
indicated by [~H]TdR incorporation  and resulted in  the accumulation of the 
majority of the cells in Go/Gi  by day 13  (Fig.  5B).  Thus, once lectin-activated 
cells express IL-2 receptors, it appears that the receptor levels are maintained 
only transiently, after which the asynchronous population gradually loses recep- 
tors.  Simultaneously,  cell  cycle progression  declines,  finally  resulting  in  the 
reaccumulation of all of the cells in the population in the Go/G1 phase of the cell 
cycle. 
Since the loss of IL-2 receptors occurred consistently under conditions where 
IL-2 concentrations were maintained at high levels, it seemed likely that IL-2- 
mediated receptor internalization, or the well-documented phenomenon of poly- 
peptide hormone-mediated "down regulation" of membrane receptors (23), could 
account for the receptor disappearance. However, when examined directly, as 
displayed in Table  I,  IL-2 receptor levels declined progressively whether IL-2 
was absent or maintained at high concentrations. These data also exclude the 
possibility that  IL-2  bound to  the receptor during the culture period masked 
detection of receptors by the radiolabeled IL-2-binding assay or anti-Tac fluo- 
rescence. In this respect, particular care was taken to assure the dissociation of 
bound IL-2:  Prior to  the receptor assays, cells were incubated for 2  h  in  the 1904  INTERLEUKIN  2  RECEPTORS  AND  T  CELL  GROWTH 
TABLE  I 
IL-2-independent Loss of lL-2 Receptors* 
[~H]leu,lys-I L-2-binding sites/cell 
Day of culture 
IL-2 absent  IL-2 present 
8  7,014  7,704 
10  3,081  2,971 
12  863  829 
* PHA-activated  human  peripheral  blood  lymphocytes  were  harvested 
after 7 d  of culture, washed, and replaced into culture in the absence 
and presence of exogenous, purified IL-2 (500 pM). 
absence of IL-2 to allow dissociation of bound IL-2 (t~/2 for dissociation at 37 °C, 
25  rain) (6).  Moreover, when tested directly, the data suggest that the epitope 
recognized by anti-Tac is not coincident with the binding site for IL-2, as IL-2 
concentrations  1,000-fold  in  excess  of those  required  to  saturate  the  IL-2 
receptors and  100-fold in excess of those used in the cultures (50 nM) did not 
inhibit anti-Tac binding even when submaximal concentrations of anti-Tac were 
used. 
Reactivation  of IL-2 Receptors and Cellular Proliferation.  The transient nature 
of IL-2 receptor expression provided an explanation for the variable nature of 
IL-2 responsiveness. Given previous empirical observations that IL-2 reactivity 
can be restored by reintroduction of the appropriate activating signals (13),  it 
was anticipated that the renewal of IL-2 receptor expression could explain this 
phenomenon. To explore this possibility, cells that no longer exhibited maximum 
levels of IL-2 receptors were reexposed to PHA for 2 h, washed free of lectin, 
and replaced into culture in the presence of purified IL-2. Measurement of IL- 
2 receptors after 24 h revealed that the population had regained maximum IL- 
2 receptor expression (Fig. 6A). Moreover, the reappearance of IL-2 receptors 
occurred in  a  more synchronous fashion after the secondary inductive signal 
than after the primary signal. In particular, it was notable from analyses of anti- 
Tac reactivity that within 24 h of second iectin exposure, the population changed 
from a relatively homogenous state with low levels of anti-Tac labeling (Fig. 6B) 
to a  population  with high  mean [3H]leu,lys-IL-2-binding levels that exhibited 
marked heterogeneity with respect to anti-Tac reactivity (Fig. 6 C). 
The reappearance of IL-2 receptors was followed by a lag phase of 24-48 h 
before the  onset  of renewed cell  proliferation.  This Could  be  monitored by 
[3H]TdR incorporation and PI analysis, both of which indicated significant cell 
cycle progression after the reinduction of receptors for IL-2. However, over a 
period of several days it was again evident that the population did not maintain 
IL-2 receptor expression (Fig. 6). Furthermore, this second diminution in recep- 
tor levels was accompanied by a decline in the proliferative capacity of the cells. 
It was  possible  to  restimulate the cells multiple times in  order to  induce the 
appearance of IL-2 receptors (Fig. 7) and no evidence indicated that this resulted 
in  the selection of cells that could maintain  IL-2  receptor expression without 
lectin reactivation. 
Functional Implications  of Heterogeneity of lL-2 Receptor Expression.  It is notewor- 
thy that lectin-stimulated T  cell populations display a  marked heterogeneity of A. 
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FIGURE 6.  IL-2 receptor expression and proliferative response of cells after restimulation 
with  PHA.  (A)  PBM  cells harvested  after  8  d  of culture in  the  presence  of  IL-2  were 
restimulated with PHA (circles)  or left unstimulated (triangles). Solid symbols denote [SH]- 
leu,lys-I  L-2-binding  sites/cell and open symbols denote [SH]TdR incorporation. (B) Histogram 
of anti-Tac reactivity of control cell population at day 9 of culture. (C) Histogram of PHA- 
stimulated cells at day 9 of culture. 
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FIGURE 7.  The  effect  of repetiUve  PHA  stimulation on  anti-Tac antigen expression  by 
cultured human PBM cells.  Arrows indicate day of exposure to PHA. Solid symbols denote 
restimulated cells and open symbols the unstimulated controls. 
IL-2  receptor  expression as determined by the anti-Tac  monoclonal antibody 
and the cytofluorograph. This broad variation in cellular receptor density was 
also  evident  in  noncycling Go]Gt  lectin-primed T  cells,  suggesting that  such 
heterogeneity is not attributable to the cell cycle asynchrony of the proliferating 
cell population. However, there was a correlation between the intensity of anti- 
Tac  reactivity  and  the  proliferative  rate  of cells  comprising the  population, 
suggesting that IL-2 receptor density determines the proportion of cells in the 
proliferative  phase  of the  cell  cycle.  A  typical  experiment  that  supports  this 
interpretation is displayed in Fig. 8 (six additional experiments yielded identical 
results). A  cell population was synchronized into Go/Gl by IL-2 deprivation for 
96 h, restimulated with PHA to ensure the presence of IL-2 receptors (Fig. 8A), 
and then separated using the cytofluorograph into subsets on the basis of low 
(Fig. 8B) or high (Fig. 8 C) anti-Tac reactivity. The unseparated and separated 1906  INTERLEUKIN  2  RECEPTORS  AND  T  CELL  GROWTH 
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FIGURE  8.  The  proliferative  rate of ]L-2  receptor*  cell subpopulations  separated on the basis 
of cellular IL-2 receptor density. PHA-stimulated human PBM cells were synchronized into 
Go/Gj by IL-2 deprivation for 96 h.  24 h  before analysis, the cells were restimulated with 
PHA (0.5 #g/ml, 2 h exposure) to ensure maximum IL-2 receptor expression. The cells were 
then labeled with anti-Tac and fluorescein isothiocyanate-conjugated rabbit anti-mouse Ig, 
and after analysis by the cytofluorograph, viable cells were selected for high or low anti-Tac 
reactivity. The histograms of anti-Tac reactivity are shown on the left: (A) unseparated cells, 
(B) low anti-Tac fluorescence intensity cells, (C) high anti-Tac fluorescence intensity cells. The 
[SH]TdR incorporation of each population at the time of separation and after 22 h of culture 
with IL-2 (500 pM) is shown on the right. 
cell populations were exposed to saturating concentrations of IL-2 for 22 h and 
monitored for proliferative response by a 2-h exposure to [SH]TdR. As depicted, 
the rate of [3H]TdR incorporation correlated with the levels of anti-Tac reactiv- 
ity. Indeed, the data indicate that the high intensity anti-Tac + subset accounts 
for most of the proliferative activity observed in the unseparated population of 
cells. 
Discussion 
The emergence, decay, and eventual disappearance of IL-2 receptors on lectin- 
activated human T  cells, which is followed by a parallel IL-2-dependent transient 
proliferative response, provides an explanation of the variability of the in vitro 
growth of T  cells. Although the mechanism underlying the transient expression 
of IL-2  receptors  remains  obscure,  IL-2-mediated  down-regulation  does  not 
appear  to  be  responsible.  Rather,  since  repetitive  exposure  to  the  activating 
lectin results in continual receptor reexpression and, consequently, renewed IL- 
2 responsiveness, it appears that antigen/lectin recognition ultimately determines 
the extent of T  cell clonal expansion. 
For  this study, radiolabeled  IL-2  was purified by adsorption  to the  DMS-3 
monoclonal anti-IL-2.  Since the binding data obtained with this reagent were 
identical to those previously reported using biochemically purified IL-2 (5), and 
since both preparations manifested biologic activity with only one radiolabeled 
moiety detected by SDS-PAGE, the data give strong support to the conclusion 
that IL-2  binding and biologic activity reside in the same  15,500 Mr protein. 
Moreover, confirmation that the immunoaffinity-purified IL-2 is homogeneous 
was provided by SDS-PAGE,  reverse-phase liquid chromatography, and amino 
acid sequence analysis, as detailed previously (7): the amino-terminal amino acid 
sequence of immunoaffinity-purified IL-2 coincides precisely with the sequence CANTRELL AND SMITH  1907 
predicted by cloned Jurkat (24) and normal human  2 IL-2 cDNA. 
The acquisition of IL-2 receptors by the majority of T  cells within 48 h, at a 
time when only a minor proportion of cells had entered the cell cycle, is consonant 
with the view that IL-2 receptor expression occurs during GI and precedes DNA 
synthesis. Moreover, the gradual increase in receptor concentration within the 
population  that  occurs before entrance  into  the  remainder of the  cell  cycle 
suggests that a  critical threshold of cellular receptor density must be attained 
before the commitment to DNA synthesis. These data are consistent with those 
of Cotner  et al.  (25)  who  recently reported  that  the appearance of anti-Tac 
reactivity preceded  the onset of DNA  synthesis in  lectin-stimulated cultures. 
Furthermore, previous studies examining IL-2  receptor expression by cellular 
IL-2 absorption  indicate that metabolic inhibition of DNA synthesis does not 
prevent IL-2 receptor induction (26). 
Once maximal IL-2 receptor levels appear, a  marked heterogeneity of IL-2 
receptor expression persists within the total cell population as detected by anti- 
Tac  binding.  The  anti-Tac  reagent,  which  competitively inhibits  binding  of 
radiolabeled IL-2  to the IL-2  receptor (8),  permits a  qualitative assessment of 
IL-2 receptor expression, thus providing information unobtainable by the quan- 
titative radioreceptor assay. Although anti-Tac has yet to be shown to be reactive 
solely with the IL-2 receptor, in other experiments (unpublished), similar heter- 
ogeneity in receptor profiles was observed among cloned human and murine T 
cell populations using IL-2 monoclonal antibodies to detect receptor-bound IL- 
2.  Thus,  the  heterogeneity of receptor expression by  lectin-activated human 
peripheral  blood  T  cells  does  not  necessarily reflect differences in  receptor 
expression at the clonal level. Moreover, since receptor heterogeneity was also 
observed among cell populations that had accumulated in  Go/G~,  variation of 
receptor density with the different phases of the cell cycle does not account for 
this phenomenon. 
While the factors that determine the rate of receptor acquisition at the level 
of the single cell  remain  obscure,  the correlation of receptor levels with  the 
proportion of cells in the actively cycling phase of the cell cycle suggests that the 
IL-2 receptor density per cell determines cell cycle progression, especially when 
IL-2 concentrations become limiting. Thus, the sigmoid shape of the IL-2 log 
dose-response curve could reflect the heterogeneity of receptor expression within 
the cell population. At low IL-2 concentrations, those cells with a high receptor 
density would necessarily have a greater absolute number of occupied receptors, 
since  the  proportion  of receptors  occupied  is  determined by  the  free  IL-2 
concentration. Accordingly, these data lend further support to the view that the 
receptor concentration per cell is a key variable in determining the commitment 
to  DNA  synthesis,  and  furthermore,  that  an  accumulation of IL-2-occupied 
receptors  to  some  critical  threshold  must  occur  before  the  onset  of  DNA 
synthesis. 
The decay of IL-2 receptor levels upon removal of the cell population from 
the activating lectin was anticipated in view of the decline of IL-2 responsiveness 
2  Clark, S. C., et al. Human T cell growth factor: partial amino acid sequence of the proteins 
expressed by normal  and leukemic  cells, molecular  cloning  of the mRNA  from normal  cells,  analysis 
of gene structure and expression  in different human  cell types. Manuscript  submitted  for publication. 1908  INTERLEUKIN 2  RECEPTORS AND T  CELL GROWTH 
that we and others have encountered in attempts to generate  IL-2-dependent 
long-term T  cell lines (13).  However, in these earlier experiments it was impos- 
sible to determine whether the loss of IL-2 responsiveness was a consequence of 
diminished concentrations of potential activating signals, the presence of toxic 
components in the  IL-2-containing medium used, or an  IL-2-mediated down- 
regulation of IL-2 receptors (23).  Thus, with the availability of homogeneous, 
affinity-purified IL-2,  it was possible to provide evidence that the loss of IL-2 
responsiveness occurs as a  result of an IL-2-independent, progressive decay of 
cellular IL-2 receptors. This conclusion is strengthened by the observation that 
IL-2  receptor  expression  is  necessary  for  IL-2  responsiveness  within  a  cell 
population, and in addition, by the observation that the IL-2-dependent prolif- 
erative response decays in parallel with IL-2 receptor loss. IL-2 receptor reexpres- 
sion upon repetitive exposure to the activating lectin, followed by a renewal of 
IL-2-dependent proliferation, indicates decisively that the maintenance of con- 
tinuous  T  cell  clonal  expansion  is  dependent  upon  the  reinduction  of  IL-2 
receptors. Furthermore, subsequent studies (unpublished) indicate similar kinet- 
ics of IL-2 receptor induction and disappearance in aUoantigen-activated T  cell 
populations.  Thus,  the  maintenance  of  IL-2  receptor  expression  and  IL-2- 
dependent proliferative response is strictly antigen/lectin dependent. 
The kinetics of lectin-initiated IL-2 receptor appearance and disappearance 
observed in the present experiments are remarkably similar to those described 
originally  by  MacDonald  et  al.  (27),  who  were  the  first  to  demonstrate  the 
maintenance of alloantigen-specific murine CTL in continuous culture by repet- 
itive  alloantigen  stimulation.  In  their  study,  the  proliferation  of alloantigen- 
activated CTL peaked at 4-5  d  and gradually subsided to low levels by  14-21 
d. Moreover, during this interval, the CTL underwent a blastogenic change in 
morphology followed by a  gradual  diminution in  cell  size  that  paralleled  the 
decay of proliferative and cytolytic activity. Upon the reintroduction of allogeneic 
stimulator  cells,  the  CTL  regained  maximum  cytolytic  activity  within  24  h, 
before the onset of DNA synthesis.  Moreover, these accelerated kinetics were 
also observed when in vivo primed T  cells were secondarily activated in vitro. 
Of particular  interest  is the interpretation  that the more rapid reinduction of 
cytolytic capacity after the secondary stimulation in vitro resembles an anamnestic 
immune response (27). In this context, "memory" T  cells acquire their immune- 
specific cytolytic function  in  vitro  much  more  rapidly  than  unprimed T  cell 
populations. The rapid reappearance of maximal IL-2 receptor levels observed 
upon secondary stimulation is reminiscent of these early classic studies. Assuming 
adequate IL-2 concentrations, the more rapid acquisition of IL-2 receptors by 
the total cell population would explain the accelerated nature of the anamnestic 
response  compared  with  the  slowly  progressive  acquisition  of IL-2  receptors 
demonstrated by an unprimed cell population. Consequently, it is attractive to 
view a  memory T  cell  as  a  cell  that  once  expressed  IL-2  receptors  and  had 
subsequently lost them. 
The basis for the different kinetic parameters of receptor expression between 
the primed and unprimed cells remains obscure. It is possible that the reactivation 
of primed cells results in the expression of a presynthesized receptor population 
whereas  de  novo  synthesis  of receptors  may  be  required  by  unprimed  cells. CANTRELL  AND  SMITH  1909 
Alternatively, it is conceivable that during the initial IL-2-dependent proliferative 
phase  there  is  selection for  cells  that  somehow express  IL-2  receptors more 
rapidly, so that  upon restimulation, receptor induction occurs synchronously. 
However, the salient observation remains the more rapid receptor reexpression 
by the primed cell population, whatever the mechanism, for this feature confers 
a biologic advantage to the primed cells compared with the naive population. 
The immunologic relevance of the present study resides in the understanding 
it provides regarding the mechanism whereby external environmental stimuli 
direct the magnitude and extent of T  cell clonal expansion by means of the IL- 
2 hormone receptor system. Immunologic specificity is ensured by the antigen 
dependence of IL-2 receptor expression.  Moreover, reason dictates that  IL-2 
receptor expression should be only transient after each antigenic stimulation. 
Otherwise, with the continual exposure to new antigens, previously activated T 
cell  clones  would  also  be  equipped  to  proliferate,  provided  adequate  IL-2 
concentrations are available. Thus, if the present data are extrapolated to the in 
vivo behavior of antigen-activated T  cells, it would be anticipated that after the 
initial IL-2-driven expansion ofa T cell clone, as antigen is cleared, IL-2 receptors 
within the clone would diminish, leading to the cessation of cell proliferation. 
Thus, it is a reasonable expectation that a further understanding of the molecular 
mechanism whereby antigen or lectin stimulation leads to IL-2 receptor expres- 
sion, and of the factors responsible for the loss of receptors, will provide the 
insight essential to elucidate the regulation of both physiologic and pathophys- 
iologic T  cell immune responses. 
Summary 
T  lymphocyte mitosis results from the interaction of interleukin 2 (IL-2) with 
specific receptors that appear only after appropriate immune stimulation. To 
assess  the potential role of IL-2  receptor levels in determining the rate  and 
magnitude of T  cell proliferation, the expression of IL-2 receptors by lectin- 
stimulated human peripheral blood T  cells was examined and correlated with T 
cell growth. Using biosynthetically radiolabeled IL-2 and anti-Tac, a monoclonal 
antibody  that  blocks  IL-2  receptor  binding,  IL-2  receptors  were  found  to 
accumulate slowly and asynchronously among lectin-stimulated T  cells and to 
precede  the  onset of DNA  synthesis.  Moreover,  a  critical  threshold of IL-2 
receptor density appeared to be required before the commitment to cell cycle 
progression, as analyzed quantitatively by tritiated thymidine incorporation and 
flow cytometric analysis of cellular DNA content. Once maximal IL-2 receptor 
expression occurred, continued proliferation was IL-2 concentration dependent 
as assessed using homogenous immunoaffinity-purified IL-2. Upon removal of 
the activating lectin, IL-2 receptor levels progressively declined, and, in parallel, 
the rate of proliferation diminished. The decay of IL-2 receptors could not be 
attributed to  IL-2-mediated down-regulation. Instead, renewed IL-2 receptor 
expression was dependent upon the reintroduction of the initial activating signal. 
Repetitive exposure to lectin resulted in a more rapid reexpression of maximal 
IL-2 receptor levels, which was then followed by an accelerated resumption of 
proliferation. Thus, the extent of T  cell proliferation after immune stimulation 
depends upon the interplay of the IL-2 concentration available and the density I910  INTERLEUKIN  2  RECEPTORS  AND T  CELL GROWTH 
of I L-2 receptors expressed, both of which are ultimately determined by antigen/ 
iectin stimulation.  The awareness  of the transience and  the antigen/lectin  de- 
pendence of IL-2 receptor expression, together with the capacity to monitor T 
cell cultures for IL-2 receptor levels, should facilitate the initiation and mainte- 
nance of cloned, antigen-specific T  cells in long-term culture. In addition, these 
findings  suggest  that,  in  vivo,  the  rapidity  of acquisition  of  maximum  IL-2 
receptor levels by activated T  cells and the duration of IL-2 receptor expression 
may well direct the magnitude of T  cell clonal expansion and resultant immune 
responses. 
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